ARTICLE | Company News
Nippon Kayaku licenses apaziquone in Asia
November 11, 2009 1:49 AM UTC
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) granted Nippon Kayaku Co. Ltd. (Tokyo:4272) exclusive Asian rights to develop and commercialize apaziquone. The analog of mitomycin C is in Phase III testin...